Hepatitis B virus (HBV) reactivation is commonly observed in individuals with chronic HBV infection undergoing antineoplastic drug therapy. Paclitaxel (PTX) treatment has been identified as a ...

Hepatitis B virus (HBV) reactivation is commonly observed in individuals with chronic HBV infection undergoing antineoplastic drug therapy. Paclitaxel (PTX) treatment has been identified as a ...

Two cross-sectional, one validation cohort, and meta-analyses were used to explore the relationship between HBV replication and liver inflammation. Spearman analysis, multiple linear regression, and ...

PARIS — People with HIV and resolved HBV infection who switched from tenofovir-based antiretroviral therapy (ART) to tenofovir-sparing regimens did not see clinically meaningful hepatitis B virus (HBV ...

Hepatitis B virus (HBV) reactivation may occur if someone has chronic HBV, prior exposure to HBV and is undergoing treatment, or a health condition that suppresses their immune system. The hepatitis B ...

As part of their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) can establish an infection in liver cells, researchers led by teams at Memorial Sloan ...

Weekly AHB-137 300 mg for 16 weeks achieved HBV DNA <10 IU/mL in 100% and complete response in 68% at end of treatment without concomitant nucleos(t)ide analogues. Baseline HBsAg stratified outcomes, ...

C. elegans as a new animal model for treating HBV We are in the process of mapping and cloning the hids genes. We also initiated a large-scale drug screen in C. elegans to isolate compounds that ...

ELIMINATE-B Phase 1 dose finding study for chronic Hepatitis B executing on schedule with completion of first dose administration for cohort 1 (n=3 patients) PBGENE-HBV, the first LNP gene editing ...